Bhandari et al., 2015 - Google Patents
Reproductive outcome of patients with Asherman's syndrome: a SAIMS experienceBhandari et al., 2015
View HTML- Document ID
- 11114017951946254467
- Author
- Bhandari S
- Bhave P
- Ganguly I
- Baxi A
- Agarwal P
- Publication year
- Publication venue
- Journal of reproduction & infertility
External Links
Snippet
Background: The purpose of the study was to evaluate menstrual and reproductive outcome in patients diagnosed with Asherman's syndrome on hysteroscopy and to assess the role of hysteroscopic adhesiolysis. Methods: A prospective study was performed for patients having …
- 206010053868 Asherman's syndrome 0 title abstract description 33
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bhandari et al. | Reproductive outcome of patients with Asherman’s syndrome: a SAIMS experience | |
| Vannuccini et al. | Recent advances in understanding and managing adenomyosis | |
| Farquhar et al. | Female subfertility | |
| Oliveira et al. | Uterine cavity findings and hysteroscopic interventions in patients undergoing in vitro fertilization–embryo transfer who repeatedly cannot conceive | |
| Pérez-Medina et al. | Endometrial polyps and their implication in the pregnancy rates of patients undergoing intrauterine insemination: a prospective, randomized study | |
| Pabuçcu et al. | Reproductive outcome after hysteroscopic metroplasty in women with septate uterus and otherwise unexplained infertility | |
| Bonin et al. | Predictive factors for the methotrexate treatment outcome in ectopic pregnancy: A comparative study of 400 cases | |
| Bakas et al. | Hysteroscopic resection of uterine septum and reproductive outcome in women with unexplained infertility | |
| Shokeir et al. | Determinants of fertility and reproductive success after hysteroscopic septoplasty for women with unexplained primary infertility: a prospective analysis of 88 cases | |
| Ferrero et al. | Impact of large ovarian endometriomas on the response to superovulation for in vitro fertilization: A retrospective study | |
| Abuzeid et al. | Reproductive outcome after IVF following hysteroscopic division of incomplete uterine septum/arcuate uterine anomaly in women with primary infertility | |
| Wang et al. | Hysteroscopic septum resection of complete septate uterus with cervical duplication, sparing the double cervix in patients with recurrent spontaneous abortions or infertility | |
| Wang et al. | Primary ovarian pregnancy: a case series and analysis | |
| Pabuçcu et al. | Impact of office hysteroscopy in repeated implantation failure: Experience of a single center | |
| Marcus et al. | Tuberculous infertility and in vitro fertilization | |
| Zhang et al. | Analysis of risk factors for obstetric outcomes after hysteroscopic adhesiolysis for Asherman syndrome: A retrospective cohort study | |
| Eserol et al. | The effect of diagnostic hysteroscopy performed before fresh and frozen-thawed embryo transfer in IVF cycles on reproductive outcomes | |
| Wang et al. | Concomitant adenomyosis among patients with asherman syndrome | |
| Ocal et al. | Recurrent implantation failure is more frequently seen in female patients with poor prognosis | |
| Ammar et al. | Effect of oral Tadalafil on endometrial thickness in patients receiving Clomiphene citrate for ovulation induction | |
| Koniares et al. | Evaluation and management of infertility for patients without insurance coverage | |
| Liu et al. | The diagnostic value of transvaginal color Doppler ultrasonography plus serum β-HCG dynamic monitoring in intrauterine residue after medical abortion | |
| Palshetkar et al. | Role of hysteroscopy prior to assisted reproductive techniques | |
| Machtinger et al. | Medical treatment with misoprostol for early failure of pregnancies after assisted reproductive technology: a promising treatment option | |
| Amer-Alshiek et al. | What is the right timing for ultrasound evaluation after pregnancy termination with mifepristone? |